These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15802733)
1. Risks of gene therapy should be weighed against lack of alternatives for many diseases. MacLaren RE; Ali RR; Thrasher AJ BMJ; 2005 Apr; 330(7494):791. PubMed ID: 15802733 [No Abstract] [Full Text] [Related]
2. Panel advises resuming genetic studies: U.S. agency halted trials after boy fell ill in French experiment. Stolberg SG N Y Times Web; 2002 Oct; ():A30. PubMed ID: 12474841 [No Abstract] [Full Text] [Related]
3. Trials are halted on gene therapy: child in experiment falls ill--new setback for research. Stolberg SG N Y Times Web; 2002 Oct; ():A1, A25. PubMed ID: 12474837 [No Abstract] [Full Text] [Related]
4. FDA halts 27 gene therapy trials after illness: leukemia-like cases in 2 children in France prompt the action. Pollack A N Y Times Web; 2003 Jan; ():A1, A17. PubMed ID: 12647754 [No Abstract] [Full Text] [Related]
6. Rules on gene therapy are tightened after leukaemia alert. Hargreaves S BMJ; 2002 Oct; 325(7368):791. PubMed ID: 12376429 [No Abstract] [Full Text] [Related]
7. Cancer scare hits gene cures: a second major setback for medicine's most pioneering treatment has split the scientific community. Could a moratorium do more harm than good? Dixon N New Sci; 2002 Oct; 176(2364):4-5. PubMed ID: 12731517 [No Abstract] [Full Text] [Related]
8. Risks inherent in fetal gene therapy. King D; Shakespeare T; Nicholson R; Clarke A; McLean S Nature; 1999 Feb; 397(6718):383. PubMed ID: 9989397 [No Abstract] [Full Text] [Related]
9. Gene therapy: two steps forward, one step back. Johnston J; Baylis F CMAJ; 2004 Jun; 170(12):1785-6. PubMed ID: 15184327 [No Abstract] [Full Text] [Related]
10. FDA halts gene therapy trials after leukaemia case in France. Marwick C BMJ; 2003 Jan; 326(7382):181. PubMed ID: 12543825 [No Abstract] [Full Text] [Related]
11. Gene therapy. What to do when clear success comes with an unclear risk? Marshall E Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304 [No Abstract] [Full Text] [Related]
12. Risks and benefits of gene therapy. Noguchi P N Engl J Med; 2003 Jan; 348(3):193-4. PubMed ID: 12529458 [No Abstract] [Full Text] [Related]
13. Gene therapy in the clinic: whose risks? Ashcroft RE Trends Biotechnol; 2004 Nov; 22(11):560-3. PubMed ID: 15491799 [TBL] [Abstract][Full Text] [Related]
14. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. McCormack MP; Rabbitts TH N Engl J Med; 2004 Feb; 350(9):913-22. PubMed ID: 14985489 [No Abstract] [Full Text] [Related]
15. Good news for gene therapy. Berns A N Engl J Med; 2004 Apr; 350(16):1679-80. PubMed ID: 15084702 [No Abstract] [Full Text] [Related]